Nicholas DeVito/LinkedIn
Jul 8, 2025, 10:22
Nicholas DeVito: Doc Talk for COLONTOWN on Tumor Immunology and BOT/BAL in MSS CRC
Nicholas DeVito, Assistant Professor of Medicine at Duke University, shared a post on LinkedIn:
“I recently gave a doc talk for COLONTOWN on tumor immunology and immunotherapies like BOT/BAL, highlighting our first-line investigator-initiated trial in MSS CRC. Appreciate the invitation to speak and opportunity to listen to patient/supporter questions!”
You can find more posts featuring Nicholas DeVito in OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 8, 2025, 13:38
Jul 8, 2025, 13:27
Jul 8, 2025, 13:19
Jul 8, 2025, 12:55
Jul 8, 2025, 12:23
Jul 8, 2025, 12:14